drugset / Trial / NCT00225342

Study Protocol for Rosiglitazone Versus Gliclazide in Diabetics With Angina

NCT00225342

Phase 4 Withdrawn 60 enrolled University of Glasgow GlaxoSmithKline · collab
RandomizedParallel-groupDouble-blindTreatment

Summary

The principle objective of the trial is to compare rosiglitazone to gliclazide in patients with type 2 diabetes mellitus and chronic stable angina to see how the subjects' angina status changes. Angina status will be measured via exercise tolerance testing, 24-hour ECG testing and angina quality of life questionnaire.

Timeline

Start
Primary completion
Completion

Drugs

EvaluationDrugModalityDoseRoute
Subject Gliclazide Small molecule
Subject Rosiglitazone Small molecule